ESC 365 - TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity

HFA Premium Access

TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity

Session: Poster Session 1 - Basic Science: Co-morbidities

Topic: Cancer/Cardiotoxicity

Speaker: Assistant Professor M. Trofenciuc (Arad, RO)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Assistant Professor Mihai-Nelu Trofenciuc

Vasile Goldis Western University, Arad (Romania)

1 presentation

1 follower

4 more presentations in this session

Enalapril, eplerenone or their combination: finding the best paradigm to protect against Doxorubicin-Induced Cardiotoxicity

Speaker: Professor R. Hullin (Lausanne, CH)

Ranolazine protects from trastuzumab cardiomyopathy

Speaker: Doctor N. Maurea (Naples, IT)

Sildenafil treatment in a rat model of cancer cachexia

Speaker: Doctor S. Nucera (Catanzaro, IT)

Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity in vitro and in vivo

Speaker: Professor W. Kim (Seoul, KR)

Access the full session

Poster Session 1 - Basic Science: Co-morbidities

Speakers: Assistant Professor M. Trofenciuc, Professor R. Hullin, Doctor N. Maurea, Doctor S. Nucera, Professor W. Kim

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources